Note that some links may require subscriptions.
Roche said the FDA approved its immunotherapy drug atezolizumab (Tecentriq) for first-line treatment of non-small cell lung cancer negative for ALK and EGFR mutations, in combination with bevacizumab (Avastin), paclitaxel, and carboplatin.
The FDA decided that antiseptic hand cleaners used by food handlers differ enough from products used in other settings to require separate regulation and has begun taking steps to develop regulations.
Ebola cases have emerged in the Congolese city of Butembo, population 1 million-plus, and officials said supplies of investigational vaccines used to help contain the outbreak are running short. (AP)
The National Institute for Health and Care Excellence, England’s healthcare cost-effectiveness agency, gave a thumbs up to the CAR T-cell therapy axicabtagene ciloleucel (Yescarta) for selected patients with certain recurrent, aggressive lymphomas.
Several major retailers — including Walmart and CVS — could have tight supplies of infant ibuprofen for awhile as a result of a recall related to lots potentially containing higher-than-advertised concentrations of the drug. (USA Today)
Walgreens and FedEx have partnered to offer next-day prescription delivery to compete with Amazon. (CNBC)
Morning Break is a daily guide to what’s new and interesting on the Web for healthcare professionals, powered by the MedPage Today community. Got a tip? Send it to us: MPT_editorial@everydayhealthinc.com